Vision-Sciences Company Profile (NASDAQ:CGNT)

About Vision-Sciences

Vision-Sciences logoCogentix Medical, Inc., formerly Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes, otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CGNT
  • CUSIP:
Key Metrics:
  • Previous Close: $1.73
  • 50 Day Moving Average: $1.69
  • 200 Day Moving Average: $1.20
  • 52-Week Range: $0.71 - $1.99
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -21.63
  • P/E Growth: -0.54
  • Market Cap: $45.23M
  • Outstanding Shares: 26,144,000
  • Beta: 0.6
  • Net Margins: -13.99%
  • Return on Equity: -27.43%
  • Return on Assets: -8.85%
  • Debt-to-Equity Ratio: 1.77%
  • Current Ratio: 1.98%
  • Quick Ratio: 1.27%
Additional Links:
Companies Related to Vision-Sciences:

Analyst Ratings

Consensus Ratings for Vision-Sciences (NASDAQ:CGNT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $1.15 (33.53% downside)

Analysts' Ratings History for Vision-Sciences (NASDAQ:CGNT)
DateFirmActionRatingPrice TargetDetails
9/7/2016Roth CapitalUpgradeNeutral -> BuyView Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Vision-Sciences (NASDAQ:CGNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q2$0.01($0.10)ViewN/AView Earnings Details
3/3/2016Q4($0.07)($0.04)ViewN/AView Earnings Details
11/3/2015Q216($0.07)($0.09)$11.45 million$11.80 millionViewN/AView Earnings Details
8/10/2015Q116($0.10)($0.14)$11.34 million$11.20 millionViewListenView Earnings Details
5/14/2015Q415($0.06)($0.15)$49.10 million$7.00 millionViewListenView Earnings Details
2/5/2015Q315($0.03)$4.92 million$4.51 millionViewListenView Earnings Details
8/4/2014Q115($0.04)$3.65 million$3.75 millionViewN/AView Earnings Details
2/3/2014Q3 14($0.03)$4.00 million$4.50 millionViewN/AView Earnings Details
8/12/2013Q1 2014($0.05)$34.00 million$3.70 millionViewN/AView Earnings Details
11/5/2012Q213($0.06)($0.07)$3.85 million$3.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Vision-Sciences (NASDAQ:CGNT)
Current Year EPS Consensus Estimate: $-0.21 EPS
Next Year EPS Consensus Estimate: $-0.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.05)($0.03)($0.04)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.04)($0.04)($0.04)
Q4 20161($0.03)($0.03)($0.03)
Q1 20171($0.04)($0.04)($0.04)
Q2 20171($0.01)($0.01)($0.01)
Q3 20171($0.02)($0.02)($0.02)
Q4 20171($0.01)($0.01)($0.01)
(Data provided by Zacks Investment Research)


Dividend History for Vision-Sciences (NASDAQ:CGNT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Vision-Sciences (NASDAQ:CGNT)
Insider Ownership Percentage: 35.50%
Institutional Ownership Percentage: 30.47%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/10/2016Lewis C PellDirectorBuy13,291$0.95$12,626.45View SEC Filing  
6/1/2016Lewis C PellDirectorBuy894$0.75$670.50View SEC Filing  
5/31/2016Lewis C PellDirectorBuy500,000$0.79$395,000.00View SEC Filing  
5/21/2015Kevin H RocheDirectorBuy10,000$1.68$16,800.00View SEC Filing  
5/19/2015Kevin H RocheDirectorBuy10,000$1.60$16,000.00View SEC Filing  
2/20/2015Lewis C PellDirectorBuy20,000$0.51$10,200.00View SEC Filing  
2/19/2015Lewis C PellDirectorBuy10,000$0.48$4,800.00View SEC Filing  
2/18/2015Lewis C PellDirectorBuy30,000$0.45$13,500.00View SEC Filing  
2/13/2015Lewis C PellDirectorBuy20,000$0.47$9,400.00View SEC Filing  
2/11/2015Lewis C PellDirectorBuy35,000$0.46$16,100.00View SEC Filing  
12/23/2014Lewis C PellDirectorBuy80,000$0.85$68,000.00View SEC Filing  
12/22/2014Lewis C PellDirectorBuy40,000$0.86$34,400.00View SEC Filing  
9/23/2014Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
9/19/2014Lewis C PellDirectorBuy3,900$1.00$3,900.00View SEC Filing  
9/17/2014Lewis C PellDirectorBuy5,000$1.02$5,100.00View SEC Filing  
9/16/2014Lewis C PellDirectorBuy5,000$1.07$5,350.00View SEC Filing  
9/12/2014Lewis C PellDirectorBuy23,300$1.04$24,232.00View SEC Filing  
9/8/2014Lewis C PellDirectorBuy30,000$1.04$31,200.00View SEC Filing  
9/3/2014Lewis C PellDirectorBuy30,000$0.98$29,400.00View SEC Filing  
8/27/2014Lewis C PellDirectorBuy10,000$0.92$9,200.00View SEC Filing  
8/26/2014Lewis C PellDirectorBuy30,000$0.93$27,900.00View SEC Filing  
8/19/2014Lewis C PellDirectorBuy22,900$0.98$22,442.00View SEC Filing  
8/13/2014Lewis C PellDirectorBuy43,420$0.91$39,512.20View SEC Filing  
8/8/2014Lewis C PellDirectorBuy27,500$0.95$26,125.00View SEC Filing  
6/6/2014Lewis C PellDirectorBuy10,000$1.13$11,300.00View SEC Filing  
5/21/2014Lewis C PellDirectorBuy5,000$1.09$5,450.00View SEC Filing  
5/16/2014Lewis C PellDirectorBuy14,197$1.02$14,480.94View SEC Filing  
11/18/2013Lewis C PellDirectorBuy6,296$0.91$5,729.36View SEC Filing  
11/15/2013Lewis C PellDirectorBuy20,000$0.90$18,000.00View SEC Filing  
9/18/2013Lewis C PellDirectorBuy16,000$0.91$14,560.00View SEC Filing  
9/13/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/10/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/9/2013Lewis C PellDirectorBuy4,564$0.95$4,335.80View SEC Filing  
9/6/2013Lewis C PellDirectorBuy5,000$0.97$4,850.00View SEC Filing  
9/3/2013Lewis C PellDirectorBuy11,432$0.97$11,089.04View SEC Filing  
8/29/2013Lewis C PellDirectorBuy1,100$0.98$1,078.00View SEC Filing  
8/27/2013Lewis C PellDirectorBuy11,596$0.97$11,248.12View SEC Filing  
8/26/2013Lewis C PellDirectorBuy14,965$0.97$14,516.05View SEC Filing  
8/19/2013Lewis C PellDirectorBuy25,025$0.94$23,523.50View SEC Filing  
8/15/2013Lewis C PellDirectorBuy15,000$0.92$13,800.00View SEC Filing  
6/28/2013Lewis C PellDirectorBuy28,400$1.00$28,400.00View SEC Filing  
6/27/2013Lewis C PellDirectorBuy45,048$0.99$44,597.52View SEC Filing  
3/15/2013Lewis C PellDirectorBuy30,000$1.14$34,200.00View SEC Filing  
3/12/2013Lewis C PellDirectorBuy45,000$1.10$49,500.00View SEC Filing  
3/7/2013Lewis C PellDirectorBuy60,000$1.09$65,400.00View SEC Filing  
3/4/2013Lewis C PellDirectorBuy20,000$1.06$21,200.00View SEC Filing  
2/26/2013Lewis C PellDirectorBuy66,266$1.01$66,928.66View SEC Filing  
2/21/2013Lewis C PellDirectorBuy25,000$0.99$24,750.00View SEC Filing  
2/19/2013Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
2/7/2013Lewis C PellDirectorBuy9,000$0.99$8,910.00View SEC Filing  
2/5/2013Lewis C PellDirectorBuy25,000$1.01$25,250.00View SEC Filing  
2/1/2013Lewis C PellDirectorBuy10,000$1.09$10,900.00View SEC Filing  
12/27/2012Lewis C PellDirectorBuy10,000$1.07$10,700.00View SEC Filing  
12/17/2012Lewis C PellDirectorBuy21,600$1.10$23,760.00View SEC Filing  
12/13/2012Lewis C PellDirectorBuy18,961$1.10$20,857.10View SEC Filing  
12/10/2012Lewis C PellDirectorBuy6,656$1.10$7,321.60View SEC Filing  
12/3/2012Lewis C PellDirectorBuy8,360$1.10$9,196.00View SEC Filing  
11/30/2012Lewis C PellDirectorBuy45,748$1.10$50,322.80View SEC Filing  
11/27/2012Lewis C PellDirectorBuy3,593$1.10$3,952.30View SEC Filing  
11/23/2012Lewis C PellDirectorBuy39,357$1.09$42,899.13View SEC Filing  
11/19/2012Lewis C PellDirectorBuy57,050$1.08$61,614.00View SEC Filing  
11/14/2012Lewis C PellDirectorBuy100,000$1.15$115,000.00View SEC Filing  
11/12/2012Lewis C PellDirectorBuy24,852$1.17$29,076.84View SEC Filing  
9/6/2012Lewis C PellDirectorBuy10,000$1.37$13,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Vision-Sciences (NASDAQ:CGNT)
DateHeadline logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:CGNT) - September 26 at 4:25 PM logoCogentix Medical to Participate in the Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:CGNT) - September 20 at 10:01 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other (NASDAQ:CGNT) - September 13 at 9:00 AM logo[$$] Accelmed Making $25 Million Equity Investment in Cogentix (NASDAQ:CGNT) - September 7 at 9:15 PM logoCogentix Medical Enters Into Definitive Agreement For $25 Million Equity Investment (NASDAQ:CGNT) - September 7 at 8:56 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity (NASDAQ:CGNT) - September 7 at 8:56 AM logo"Vision-Sciences, Inc. (CGNT) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research (NASDAQ:CGNT) - August 18 at 11:41 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 10-Q, Quarterly Report (NASDAQ:CGNT) - August 15 at 11:26 AM logoEdited Transcript of CGNT earnings conference call or presentation 2-Aug-16 8:30pm GMT (NASDAQ:CGNT) - August 3 at 12:14 PM logoCogentix Medical Reports 17 Percent Q2 Revenue Growth (NASDAQ:CGNT) - August 2 at 9:47 PM logoLook at Aug 2 Medical Instrument Earnings: IDXX, DXCM, CGNT (NASDAQ:CGNT) - August 1 at 8:07 AM logoCogentix Medical to Report Second Quarter Results on August 2, 2016 (NASDAQ:CGNT) - July 20 at 7:00 AM logoCogentix names CEO after management shake-up (NASDAQ:CGNT) - July 12 at 9:39 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CGNT) - June 22 at 4:06 PM logoHealthcare Industry Leader Kenneth A. Samet Joins Cogentix Medical Board of Directors (NASDAQ:CGNT) - June 22 at 7:19 AM logoCogentix re-hires CFO who left five months ago (NASDAQ:CGNT) - June 16 at 8:34 AM logoBrett Reynolds Rejoins Cogentix Medical As Chief Financial Officer (NASDAQ:CGNT) - June 15 at 7:19 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh (NASDAQ:CGNT) - June 15 at 7:06 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S (NASDAQ:CGNT) - June 6 at 4:16 PM logoInsiders Roundup: Buy of Advance Auto Parts, Sale of Fitbit (NASDAQ:CGNT) - June 3 at 10:15 PM logoInsiders Roundup: Buys of Advance Auto Parts, Sales of Fitbit (NASDAQ:CGNT) - June 3 at 4:15 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Prin (NASDAQ:CGNT) - May 27 at 4:29 PM logoHealthcare New Lows: Five Star Quality Care (NYSE:FVE), Cogentix Medical, Inc. (NASDAQ:CGNT), Consumer ... - KC Register (NASDAQ:CGNT) - May 26 at 2:17 PM logoCogentix CEO and two board members are out after shareholder battle (NASDAQ:CGNT) - May 26 at 2:17 PM
News IconCogentix accedes to proxy war, ousts CEO Kill (NASDAQ:CGNT) - May 26 at 2:17 PM logo8:38 am Cogentix Medical announces settlement agreement in connection with proxy contest/related litigation and leadership changes; annual meeting to be held May 24 at 1pm ET (NASDAQ:CGNT) - May 24 at 8:38 AM logoCogentix Medical Announces Settlement Agreement in Connection with Proxy Contest and Related Litigation and Leadership Changes; Annual Meeting To Be Held May 24, 2016 at 12:00 P.M. Central Daylight Time (NASDAQ:CGNT) - May 24 at 8:35 AM logoCogentix Medical Adjourns May 20, 2016 Annual Meeting in Response to Court Ruling; Adjourned Meeting Date Set for May 24, 2016 at 12:00 P.M. Central Daylight Time (NASDAQ:CGNT) - May 20 at 6:23 PM logoCogentix Medical Postpones May 20, 2016 Annual Meeting in Response to Court Ruling; New Meeting Date Set for May 24, 2016 at 12:00 P.M. Central Daylight Time (NASDAQ:CGNT) - May 20 at 5:53 AM logo/C O R R E C T I O N -- Cogentix Medical, Inc./ (NASDAQ:CGNT) - May 9 at 4:28 PM logoThe Nation's Two Leading Independent Proxy Advisory Firms Recommend Support Of Cogentix Medical Board Proposals (NASDAQ:CGNT) - May 9 at 11:38 AM logoEdited Transcript of CGNT earnings conference call or presentation 5-May-16 8:30pm GMT (NASDAQ:CGNT) - May 6 at 3:57 PM logoCogentix Medical Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:CGNT) - May 5 at 4:30 PM logoCogentix Medical Achieves Second Consecutive Quarter of Cash Operating Profit; Reports 74% Revenue Growth for the Quarter Ended March 31, 2016 (NASDAQ:CGNT) - May 5 at 4:21 PM logoCogentix Medical's (CGNT) CEO Rob Kill on Q4 2015 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:CGNT) - March 5 at 2:54 PM
News IconSteady Stock: Cogentix Medical (NASDAQ:CGNT) - CWRU Observer (NASDAQ:CGNT) - March 5 at 2:54 PM
News IconStock Review: Cogentix Medical Inc (CGNT) - share market updates (press release) (NASDAQ:CGNT) - March 5 at 2:54 PM logoCogentix Medical's (CGNT) CEO Rob Kill on Q4 2015 Results - Earnings Call Transcript (NASDAQ:CGNT) - March 5 at 2:54 PM logoEdited Transcript of CGNT earnings conference call or presentation 3-Mar-16 9:30pm GMT (NASDAQ:CGNT) - March 4 at 11:48 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (NASDAQ:CGNT) - March 3 at 4:10 PM logoCogentix Medical Reports 104% Revenue Growth for the Quarter Ended December 31; Achieves Cash Operating Profit Milestone (NASDAQ:CGNT) - March 3 at 4:01 PM logoQ4 2016 Cogentix Medical Inc Earnings Release - After Market Close (NASDAQ:CGNT) - March 3 at 7:07 AM
News IconCogentix Medical Incorporated (NASDAQ:CGNT) Sellers Increased By 12.67% Their Shorts - Business Standard Tribune (NASDAQ:CGNT) - February 28 at 2:38 PM
News IconHow Analysts Feel About Cogentix Medical Inc (NASDAQ:CGNT)? - Business Standard Tribune (NASDAQ:CGNT) - February 27 at 2:43 PM logoCogentix Medical to Report 2015 Year-End Results on March 3, 2016 - PR Newswire (press release) (NASDAQ:CGNT) - February 25 at 2:58 PM logoCogentix Medical to Report 2015 Year-End Results on March 3, 2016 (NASDAQ:CGNT) - February 24 at 2:45 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Shareholder Director Nominations, Other Events (NASDAQ:CGNT) - February 19 at 4:06 PM
News IconWere Analysts Bearish Cogentix Medical Inc (NASDAQ:CGNT) This Week? - Sonoran Weekly Review (NASDAQ:CGNT) - February 16 at 2:56 PM
News IconCogentix Medical Incorporated (NASDAQ:CGNT) Sellers Covered 5.66% of Their Shorts - (NASDAQ:CGNT) - February 13 at 2:42 PM
News Icon13G Filing: Nantahala Capital Management and Cogentix Medical Inc (CGNT) (NASDAQ:CGNT) - February 10 at 8:17 PM


Vision-Sciences (NASDAQ:CGNT) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff